Legend Biotech Corp. (LEGN)
18.12
+0.06
(+0.30%)
USD |
NASDAQ |
Feb 13, 14:08
Legend Biotech Total Liabilities (Quarterly) : 693.56M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 117.67B |
| Arcellx, Inc. | 215.14M |
| Corcept Therapeutics, Inc. | 191.70M |
| Amicus Therapeutics, Inc. | 638.39M |
| Incyte Corp. | 1.803B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.713B |
| Shareholders Equity (Quarterly) | 1.011B |
| Debt to Equity Ratio | 0.4057 |
| Current Ratio | 2.865 |
| Net Debt Paydown Yield | -0.24% |